Literature DB >> 7595416

Amplification and sequence analysis of the precore and core region of the HBV genome from sera of Spanish patients with HBV2-like infections.

T Valliammai1, J M Echevarría, P León, C Tusets, T J Harrison.   

Abstract

Hepatitis B virus (HBV) infections are occasionally associated with unusual serological profiles which may be attributed to the lack of immune responsiveness of the patients or to variants of the virus. The term HBV2 was introduced to describe potential variants of HBV which do not elicit a detectable immune response to the nucleocapsid (anti-HBc) in apparently immune-competent patients. The entire nucleotide sequences of the nucleocapsid genes of viruses from two Spanish patients with HBV2-like infections are reported here. In-frame deletions and other mutations in these sequences may account, at least in part, for the unusual serological profiles of the patients. Antibody responses to viral proteins containing deletions may not be detected by commercially available assays.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7595416     DOI: 10.1002/jmv.1890460414

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  3 in total

Review 1.  The underlying mechanisms for the "isolated positivity for the hepatitis B surface antigen (HBsAg)" serological profile.

Authors:  Robério Amorim de Almeida Pondé
Journal:  Med Microbiol Immunol       Date:  2010-05-11       Impact factor: 3.402

2.  Use of PCR in resolving diagnostic difficulties potentially caused by genetic variation of hepatitis B virus.

Authors:  F J van Deursen; K Hino; D Wyatt; P Molyneaux; P Yates; L A Wallace; B C Dow; W F Carman
Journal:  J Clin Pathol       Date:  1998-02       Impact factor: 3.411

3.  Hepatitis B virus genotype E surface antigen detection with different immunoassays and diagnostic impact of mutations in the preS/S gene.

Authors:  Christophe M Olinger; Bernard Weber; Jesse A Otegbayo; Wim Ammerlaan; Natascha van der Taelem-Brulé; Claude P Muller
Journal:  Med Microbiol Immunol       Date:  2007-05-15       Impact factor: 3.402

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.